Gilead Sciences: Latest News

All news where Gilead Sciences is mentioned

01.12.2021 / 21:23

Gilead says it expects remdesivir to remain effective against omicron variant

FOSTER CITY, Calif. - Gilead Sciences, the maker of the COVID-19 treatment remdesivir, said it expects the drug to remain effective against the new COVID-19 omicron variant and will continue to conduct further laboratory testing to confirm.Remdesivir, which is sold as Veklury, is an antiviral drug used to treat hospitalized COVID-19 patients 12 and up.

Gilead Sciences South Africa covid-19 testing vaccine

Data shows remdesivir reduces risk of COVID-19 hospitalization, Gilead Sciences says

FOSTER CITY, Calif. - Gilead Sciences said its anti-viral drug Veklury, also known as remdesivir, has shown promise in lowering the risk of hospitalization among certain COVID-19 patients.Data from Phase 3 of clinical trials found remdesivir to be 87% effective at reducing hospitalizations in high-risk patients who were diagnosed early."Antiviral medications provide maximal benefit when used early in the disease course. Last summer, data from clinical trials demonstrated the benefit of remdesivir in patients hospitalized with COVID-19, even when not yet requiring oxygen.

Gilead Sciences hospital covid-19 patient

India's daily COVID-19 cases break yet another record

The pace of new COVID-19 cases in India hit a new daily world record today, topping 300,000 for the seventh day in a row as its daily deaths topped 3,000 for the first time.

Gilead Sciences city New Delhi India Britain covid-19 vaccine donates

Coronavirus: Remdesivir manufacturers cut price on govt's request. Check details here

The revised price rates are as follows:Remdesivir is considered a key anti-viral drug in the fight against COVID-19, especially in adult patients with severe complications.Seven Indian companies are producing Injection Remdesivir under voluntary licensing agreement with M/s. Gilead Sciences, USA.

Gilead Sciences Mansukh Mandaviya Usa India covid-19 Government Coronavirus

Russian firm seeks to produce COVID-19 drug remdesivir without patent

Moscow: Russian drugmaker Pharmasyntez has asked the Kremlin to allow it to produce a generic version of U.S. COVID-19 drug remdesivir, used to treat U.S.

Donald Trump Gilead Sciences Russia city Moscow hospital covid-19 president patient

Remdesivir cut coronavirus recovery time by 5 days, company’s final study suggests

remdesivir showed the treatment cut COVID-19 recovery time by five days compared with patients who got a placebo, one day faster than indicated in preliminary data, the company and researchers said on Thursday.In patients who were on oxygen when they first got the drug, remdesivir – sold under the brand Veklury – reduced recovery time by seven days compared with placebo after 29 days, according to the 1,062-patient study, published in the New England Journal of Medicine.

Gilead Sciences Canada covid-19 Coronavirus Gilead

Experts raise questions about severity of Trump's Covid-19

that is being studied for early infections. On Saturday, the president was started on a five-day course of intravenous antiviral drug remdesivir, which is sold by Gilead Sciences .

Gilead Sciences Amesh Adalja hospital covid-19 doctor infection

Coronavirus: Canada secures 150,000 vials of Remdesivir with Gilead Sciences, McKesson Canada

Minister of Public Services and Procurement Anita Anand announced on Tuesday that the government has signed new agreements with Gilead Sciences and McKesson Canada to secure supply of up to 150,000 vials of the drug Remdesivir.

Gilead Sciences Canada covid-19 Government patient Coronavirus

Covid-19 vaccine by early 2021; TB vaccine may limit deaths: Virus updates

Covid-19 vaccine as soon as possible.However, on Friday, a parliamentary panel was informed that Covid-19 vaccine is expected only by early next year.

Gilead Sciences Usa covid-19 death vaccine Department Updates

US buys up virtually the entire production of Covid-19 drug Remdesivir for the next three months

The US government has bought virtually the entire production of the Covid-19 drug Remdesivir for the next three months.

Gilead Sciences Japan Usa World Coronavirus

U.S. buys up worldwide stock of remdesivir, drug seen as potential COVID-19 treatment

remdesivir, a drug that’s proven effective for severely ill patients of the novel coronavirus — leaving hardly any for Canada and the rest of the world.The Department of Health and Human Services (HHS) announced Monday it has secured more than 500,000 treatment courses of the drug from its sole manufacturer Gilead Sciences for American hospitals through September. Each treatment course uses an average of over six vials of the drug.

Donald Trump Gilead Sciences Usa Canada covid-19 Coronavirus

Coronavirus drug remdesivir to cost $2,340 per patient in the U.S.

COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government health programs in the United States and other developed countries.Gilead Sciences announced the price Monday for remdesivir, and said the price would be $3,120 for patients with private insurance. The amount that patients pay out of pocket depends on insurance, income and other factors.“We’re in uncharted territory with pricing a new medicine, a novel medicine, in a pandemic,” Gilead’s chief executive, Dan O’Day, told The Associated Press.

Gilead Sciences Usa covid-19 Coronavirus Gilead

pharmaceutical-technology.com

22.06.2020 / 16:19

79%

513

Cipla and Hetero launch remdesivir to treat Covid-19 in India

Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.India-based companies Cipla and Hetero have separately launched remdesivir, which has been licensed from Gilead Sciences, for the treatment of Covid-19 in the country. Cipla introduced the drug in India under the brand name CIPREMI.

Gilead Sciences India covid-19 Government patient

US pharma giant seeks marketing authorisation from India for remdesivir

Remdesivir has been issued an Emergency Use Authorization by the United States Food and Drug Administration to treat hospitalised coronavirus patients

Gilead Sciences Usa India covid-19 medicines patient Coronavirus

UK patients can now be prescribed drug remdesivir that speeds up coronavirus recovery

Some patients admitted to hospital with Covid-19 are to be given access to the drug remdesivir, which has been shown to shorten recovery time.

Gilead Sciences China Usa Italy Britain France hospital covid-19 Government patient Coronavirus

pharmaceutical-technology.com

21.05.2020 / 17:23

41%

850

Beximco Pharma launches first generic remdesivir for Covid-19

Bangladesh-based generic pharmaceuticals manufacturer Beximco Pharmaceuticals has launched the first generic version of antiviral drug remdesivir, originally developed by Gilead Sciences.

Gilead Sciences Usa Bangladesh covid-19 Government medicines patient

US pharma firm Gilead Sciences likely to seek nod to market anti-viral drug remdesivir in India

NEW DELHI : US pharmaceutical giant Gilead Sciences is likely to apply to India's Central Drugs Standard Control Organisation (CDSCO) soon seeking marketing authorisation for its anti-viral drug remdesivir, which is being considered by many as a potential medication for COVID-19.

Gilead Sciences city New Delhi Usa India covid-19 SOLIDARITY patient

After US, another country approves remdesivir for coronavirus treatment

Japan has authorised the antiviral drug remdesivir to treat coronavirus patients, the government said, with an eye to approving another medication Avigan this month. This makes Japan the second country to approve the drug after US regulators authorised it on Friday for emergency use against severe cases of COVID-19.

Shinzo Abe Gilead Sciences Japan Usa India covid-19 Government patient Coronavirus

Ebola drug shown to work against coronavirus 'could cost up to $4,500 per treatment'

An Ebola drug shown to work against coronavirus could cost up to $4,500 per treatment, experts have warned.

Gilead Sciences Usa state California hospital covid-19 patient Coronavirus

Gilead in talks with Indian drugmakers to produce remdesivir for Covid treatment

NEW DELHI : US-based biopharmaceutical major Gilead Sciences said on Wednesday it is negotiating long-term voluntary licences with several generic drugmakers in India to produce remdesivir for developing countries.

Gilead Sciences city New Delhi Usa India covid-19 crisis medicines

Bangladesh's Beximco to start Covid-19 drug remdesivir production this month

NEW DELHI : One of Bangladesh's largest drugmakers, Beximco Pharmaceuticals, will start production this month of the experimental antiviral drug remdesivir, which has shown promise in fighting the new coronavirus, a senior company executive said on Tuesday.

Gilead Sciences city New Delhi Usa Bangladesh covid-19 Government patient Coronavirus

US says Remdesivir shows 'clear-cut' effect in treating coronavirus

Remdesivir has a "clear-cut" effect in helping Covid-19 patients recover, a top US scientist who oversaw a large clinical trial into the highly-anticipated antiviral has said, hailing it as proof that a drug can block the coronavirus.

Anthony Fauci Gilead Sciences Usa World US Coronavirus

US stocks open higher after Google results, hopes of potential coronavirus drug

Gilead Sciences gave an encouraging update on a potential Covid-19 treatment, while upbeat earnings reports from Boeing and Google-parent Alphabet added to the sentiment

Gilead Sciences Usa covid-19 pandemic Coronavirus

Global stocks rally Friday on Gilead’s coronavirus treatment and Boeing’s production restart

The COVID-19 pandemic has sparked widespread unemployment, but these companies are still hiring.

Gilead Sciences New York covid-19 pandemic patient Coronavirus

Trump focuses attention on possible coronavirus treatments

President Donald Trump focused attention on possible treatments for the new coronavirus on Thursday, citing potential use of a drug long used to treat malaria and some other approaches still in testing.

Donald Trump Stephen Hahn Gilead Sciences Switzerland virus covid-19 testing

United States	Cases: 46 252 513 Deaths: 750 423 Recovered: 0
India	Cases: 34 321 025 Deaths: 459 652 Recovered: 0
Brazil	Cases: 21 835 785 Deaths: 608 235 Recovered: 0
United Kingdom	Cases: 9 215 683 Deaths: 141 607 Recovered: 0
Russia	Cases: 8 494 589 Deaths: 237 619 Recovered: 0